1 / 16

รายงานการลาศึกษาต่อระดับปริญญาเอก เรื่อง cardiorenal syndrome

รายงานการลาศึกษาต่อระดับปริญญาเอก เรื่อง cardiorenal syndrome ณ Monash University, Australia (2008-2012). ผศ. พญ. สุรีย์ เลขวรรณ วิจิตร 15 May 2012. Cardiorenal syndrome.

kiral
Télécharger la présentation

รายงานการลาศึกษาต่อระดับปริญญาเอก เรื่อง cardiorenal syndrome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. รายงานการลาศึกษาต่อระดับปริญญาเอก เรื่อง cardiorenal syndrome ณ Monash University, Australia (2008-2012) ผศ.พญ.สุรีย์ เลขวรรณวิจิตร 15 May 2012

  2. Cardiorenal syndrome Hypothesis1: Indoxyl sulfate has adverse cardiac effects.Hypothesis2: MI causes renal function and structural changes over time. Increased CV morbidity & mortality Pathologic remodeling Diminished blood flow Neurohormonal activation Vasoconstriction hemodynamics Oxidative stress Diuretic therapy Inflammation Neurohormonal activation Anemia non-dialyzable uraemic toxins? Indoxyl sulfate (IS)

  3. Cardiac fibroblast Indoxyl sulfate: In vitro study Cardiac myocyte Collagen synthesis Protein synthesis THP-1 cell: Pro-inflammatory cytokine gene expression

  4. Indoxyl sulfate: In vivo study AST-120 GI tract Indoxyl sulfate (circulation) OAT1 and 3 urine

  5. Cardiac Fibrosis Sham STNx+Vehicle STNx+AST-120 0.8X 0.8X 0.8X

  6. Renal changes post-MI: In vivo study

  7. In vivo MI–AST120 study Background MI (16 weeks) renal fibrosis

  8. Serum IS Results Heart Kidney

  9. Publications • Lekawanvijit S, Adrahtas A, Kelly DJ, Kompa AR, Krum H, Wang B. Does Indoxyl Sulfate, A Uraemic Toxin, Have Direct Effects on Cardiac Fibroblasts & Myocytes? Eur Heart J 2010;31(14):1771-1779. • Krum H, Iyngkaran P, Lekawanvijit S. Pharmacological Management of the Cardiorenal Syndrome in Heart Failure. Current Heart Failure Reports 2009;6:105-111. • Lekawanvijit S, Kompa AR, Zhang Y, Wang BH, Kelly DJ, Krum H. Myocardial Infarction Impairs Renal Function, Induces Renal Interstitial Fibrosis and Increases renal KIM-1 Expression: Implications for Cardiorenal Syndrome. Am J Physiol Heart Circ Physiol. 2012 Feb 24. [Epub ahead of print] • Liu S, Lekawanvijit S, Kompa AR, Wang BH, Kelly DJ, Krum H. Cardiorenal Syndrome: Pathophysiology, Preclinical Models, Management and Potential Role of Uraemic Toxins. Clin Exp Pharmacol Physiol. 2011 Oct 20. doi: 10.1111/j.1440-1681.2011.05632.x. [Epub ahead of print] • Lekawanvijit S, Kompa A, Manabe M, Kelly DJ, Krum H. Chronic Kidney Disease-Induced Cardiac Fibrosis is Ameliorated by Reducing Circulating Levels of a Non-Dialysable Uraemic Toxin, Indoxyl Sulfate. (Under review at PLOS One) Presentation title

  10. Conference communications • Lekawanvijit S, Kompa A, Wang BH, Nishijima F, Kelly DJ, Krum H. Chronic Kidney Disease-Induced Cardiac Fibrosis is Ameliorated by Reducing Circulating Levels of a Non-Dialysable Uraemic Toxin, Indoxyl Sulfate Reducing Circulating Levels of Indoxyl Sulfate, a Non-Dialysable Uremic Toxin, Ameliorates Chronic Kidney Disease-Induced Cardiac Fibrosis. In: The Japanese Circulation Society 16-18 March 2012. Fukuoka, Japan. • Lekawanvijit S, Kompa AR, Manabe M, Kelly DJ, Krum H. Reduction of renal fibrosis as well as cardiac pro-fibrotic and pro-inflammatory mRNA expression by an oral charcoal adsorbent, AST-120, in post-MI rats. In: The American Heart Association Scientific Sessions 12-16 November 2011. Orlando, Florida, USA. • Lekawanvijit S, Kompa A, Wang BH, Nishijima F, Kelly DJ, Krum H. Chronic Kidney Disease-Induced Cardiac Fibrosis is Ameliorated by Reducing Circulating Levels of a Non-Dialysable Uraemic Toxin, Indoxyl Sulfate. In: The ASN Kidney Week, 8-13 November 2011, Philadelphia, Pennsylvania, USA. • Lekawanvijit S, Kompa AR, Manabe M, Kelly DJ, Krum H. Reducing circulating levels of a non-dialysable uraemic toxin, indoxyl sulfate, ameliorates chronic kidney disease-induced cardiac fibrosis. In: The European Society of Cardiology Congress 2011. Paris, France; European Heart Journal 2011, 32 (Abstract Supplement):1002. • Lekawanvijit S, Kompa AR, Manabe M, Wang BH, Kelly DJ, Krum H. Chronic Kidney Disease-Induced Cardiac Fibrosis is Ameliorated by Reducing Circulating Levels of a Non-Dialysable Uraemic Toxin, Indoxyl Sulfate. In: The CSANZ 59th Annual Scientific Meeting. Perth, Australia; Heart, Lung and Circulation 2011, 20;S61. • Lekawanvijit S, Kompa A, Manabe M, Kelly DJ, Krum H. An oral charcoal adsorbent, AST-120, reduces renal fibrosis as well as cardiac pro-fibrotic and pro-inflammatory mRNA expression post-MI in the rat. In: The CSANZ 59th Annual Scientific Meeting. Perth, Australia; Heart, Lung and Circulation 2011, 20;S58. • Lekawanvijit S, Kompa A, Manabe M, Kelly DJ, Krum H. Chronic Kidney Disease-Induced Cardiac Fibrosis is Ameliorated by Reducing Circulating Levels of a Non-Dialysable Uraemic Toxin, Indoxyl Sulfate. In: The American College of Cardiology 60th Annual Scientific Session and i2 Summit, April 2-5, 2011, New Orleans, Louisiana, USA; J Am Coll Cardiol 2011; 57:192.

  11. Conference communications (cont.) • Lekawanvijit S, Kompa A, Manabe M, Kelly DJ, Krum H. Chronic Kidney Disease-Induced Cardiac Fibrosis is Ameliorated by Reducing Circulating Levels of a Non-Dialysable Uraemic Toxin, Indoxyl Sulfate. In: The 44ht Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Annual Scientific Meeting. Melbourne, Australia. 28 November – 1 December, 2010. • Lekawanvijit S, Kompa A, Zhang Y, Wang BH, Kelly DJ, Krum H. Myocardial infarction impairs renal function, induces renal interstitial fibrosis and increases Kim-1 expression: Implications for the cardiorenal syndrome. In: The CSANZ 58th Annual Scientific Meeting. Adelaide, Australia; Heart, Lung and Circulation 2010, 19;S76-77. • Lekawanvijit S, Kompa A, Zhang Y, Wang BH, Kelly DJ, Krum H. Myocardial infarction impairs renal function, induces renal interstitial fibrosis and increases Kim-1 expression: Implications for the cardiorenal syndrome. In: The American Heart Association Scientific Sessions 2009. Orlando, Florida, USA; Circulation 2009, 120:S1076. • Lekawanvijit S, Adrahtas A, Kelly DJ, Kompa AR, Krum H, Wang B. Does Indoxyl Sulfate, A Uraemic Toxin, Have Direct Effects on Cardiac Fibroblasts & Myocytes? In: The CSANZ 57th Annual Scientific Meeting. Sydney, Australia; Heart, Lung and Circulation 2009, 18(suppl 3);S174. • Lekawanvijit S, Adrahtas A, Kelly DJ, Kompa AR, Krum H, Wang B. Does Indoxyl Sulfate, A Uraemic Toxin, Have Direct Effects on Cardiac Fibroblasts & Myocytes? In: The American Heart Association Scientific Sessions 2008. New Orleans, Louisiana, USA; Circulation 2008, 118(suppl 2):S338. • Lekawanvijit S, Adrahtas A, Kelly DJ, Kompa AR, Krum H, Wang B. Does Indoxyl Sulfate, A Uraemic Toxin, Have Direct Effects on Cardiac Fibroblasts & Myocytes? In: The Alfred Week Research Poster Display. 20-24 October, 2008.

  12. Acknowledgements Supervisors • Professor Henry Krum • Professor Darren Kelly • Dr. Andrew Kompa • Dr. Bing Wang • Monash University • University of Melbourne • Prince Doctor Fund • Faculty of Medicine • Chiang Mai University • Thailand

More Related